A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 11931 participants.
Also called NCT04126486
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 11,931 participants
- Sponsor
- Registry
-
NCT04126486
-
- Other papers using this trial's data
- Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm
- Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04126486. Randomized; no masking; primary purpose prevention. Start 2019-12-17 (actual); primary completion 2023-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
- Acronym
- GUARD-AF
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Intervention (Other)
- Zio®XT Monitor
- Lead sponsor
- Bristol-Myers Squibb
- Collaborator
- Pfizer
Record details
- Record id
cardio:ct-nct04126486- Content hash
bb00ff29010da4c9f40e66cc35de0cad4743b5a832907fb17d3c1c5e0763cc9e